A cancer patient seeking access to a life-saving medicine has died after her petition was reportedly listed for hearing 57 times without a final resolution, reigniting concerns over delays in cases involving access to essential medicines. The incident has prompted the Working Group on Access to Medicines to urge the judiciary to introduce an expedited mechanism for hearing urgent healthcare matters.

In a representation addressed to the Chief Justice of India, the group has requested the Supreme Court to consider measures for the time bound disposal of cases involving life saving drugs and critical treatments. It argued that prolonged legal delays can have irreversible consequences for patients battling life threatening illnesses, where timely access to treatment is often crucial for survival.

The case has renewed debate on balancing judicial processes with the urgent medical needs of patients seeking access to high cost or unapproved therapies. Public health experts noted that delays in resolving such matters can leave patients and families without viable treatment options despite approaching the courts for relief.

According to the World Health Organization (WHO), equitable and timely access to essential medicines is a cornerstone of Universal Health Coverage (UHC). However, affordability, regulatory approvals and delayed access to innovative therapies continue to pose significant challenges, particularly for patients with cancer and rare diseases.

Healthcare policy experts have called for the establishment of fast track judicial mechanisms for cases involving life-saving treatments, similar to priority hearings granted in other time sensitive matters. They believe coordinated efforts involving the judiciary, regulators, healthcare providers and policymakers are essential to ensure that legal processes do not become a barrier to timely medical care.

The incident has once again highlighted the urgent need for a patient-centric framework that ensures quicker decisions in critical healthcare cases, reinforcing the principle that access to timely treatment can be as important as the treatment itself.